心臓移植治療の世界市場 2025～2029年

心臓移植治療市場は2024-2029年に1億2,970万米ドル、予測期間中のCAGRは3％で成長すると予測されます。

当レポートでは、心臓移植治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、心血管疾患や心不全の有病率の上昇、複数の剤形の薬剤の入手可能性、心臓移植における免疫抑制剤への依存度の高さによって牽引されています。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の心臓移植治療市場の成長を促進する主な要因の1つとして、心臓移植に関する国際的な協力関係の拡大を挙げています。また、心臓移植のための技術の出現、心臓移植に関する認知度やアクセス性の向上は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavio別分析

• 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2024
• 市場の見通し 2024-2029

第5章 市場規模実績

• 心臓移植治療の世界市場 2019-2023
• 薬剤クラス別セグメント分析 2019-2023
• 流通チャネル別セグメント分析 2019-2023
• タイプ別セグメント分析 2019-2023
• 適応症別セグメント分析 2019-2023
• 地域別セグメント分析 2019-2023
• 国別セグメント分析 2019-2023

第6章 定性分析

• AIの影響：心臓移植治療の世界市場

第7章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第8章 市場セグメンテーション：薬剤クラス別

• 市場セグメント
• 比較：薬剤クラス別
• 免疫抑制剤：市場規模と予測 2024-2029
• 抗感染薬：市場規模と予測 2024-2029
• 鎮痛剤：市場規模と予測 2024-2029
• その他：市場規模と予測 2024-2029
• 市場機会：薬剤クラス別

第9章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2024-2029
• 小売薬局：市場規模と予測 2024-2029
• オンライン薬局：市場規模と予測 2024-2029
• 市場機会：流通チャネル別

第10章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 左心室補助装置（LVAD）：市場規模と予測 2024-2029
• 心臓移植：市場規模と予測 2024-2029
• 植込み型心臓除細動器（ICD）：市場規模と予測 2024-2029
• 体外式膜型人工肺（ECMO）：市場規模と予測 2024-2029
• 市場機会：タイプ別

第11章 市場セグメンテーション：適応症別

• 市場セグメント
• 比較：適応症別
• 虚血性心疾患（IHD）：市場規模と予測 2024-2029
• 拡張型心筋症（DCM）：市場規模と予測 2024-2029
• 弁膜症（VHD）：市場規模と予測 2024-2029
• 肥大型心筋症（HCM）：市場規模と予測 2024-2029
• 市場機会：適応症別

第12章 顧客情勢

• 顧客情勢の概要

第13章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2024-2029
• 欧州：市場規模と予測 2024-2029
• アジア：市場規模と予測 2024-2029
• 世界のその他の地域：市場規模と予測 2024-2029
• 米国：市場規模と予測 2024-2029
• ドイツ：市場規模と予測 2024-2029
• カナダ：市場規模と予測 2024-2029
• フランス：市場規模と予測 2024-2029
• 日本：市場規模と予測 2024-2029
• 英国：市場規模と予測 2024-2029
• インド：市場規模と予測 2024-2029
• 中国：市場規模と予測 2024-2029
• 韓国：市場規模と予測 2024-2029
• イタリア：市場規模と予測 2024-2029
• 市場機会：地域情勢別

第14章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第15章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第16章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• AbbVie Inc.
• Astellas Pharma Inc.
• Biocon Ltd.
• Dr Reddys Laboratories Ltd.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Intas Pharmaceuticals Ltd.
• LEO Pharma AS
• Lupin Ltd.
• Novartis AG
• Panacea Biotec Ltd.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

第17章 付録

The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's heart transplantation therapeutics market is segmented as below:

By Drug Class

• Immunosuppressants
• Anti-infectives
• Analgesics
• Others

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Type

• Left ventricular assist device (LVAD)
• Heart transplantation
• Implantable cardiac defibrillator (ICD)
• Extracorporeal membrane oxygenation (ECMO)

By Indication

• Ischemic heart disease (IHD)
• Dilated cardiomyopathy (DCM)
• Valvular heart disease (VHD)
• Hypertrophic cardiomyopathy (HCM)

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.

The report on the heart transplantation therapeutics market covers the following areas:

• Heart Transplantation Therapeutics Market sizing
• Heart Transplantation Therapeutics Market forecast
• Heart Transplantation Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., DR Reddys Laboratories Ltd., Endo International PLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Heart Transplantation Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 - 2023 ($ million)
• 5.2 Drug Class segment analysis 2019 - 2023
  • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
• 5.3 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.4 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ million)
• 5.5 Indication segment analysis 2019 - 2023
  • Historic Market Size - Indication Segment 2019 - 2023 ($ million)
• 5.6 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.7 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global heart transplantation therapeutics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Drug Class

• 8.1 Market segments
  • Chart on Drug Class - Market share 2024-2029 (%)
  • Data Table on Drug Class - Market share 2024-2029 (%)
• 8.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 8.3 Immunosuppressants - Market size and forecast 2024-2029
  • Chart on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
  • Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
  • Chart on Immunosuppressants - Year-over-year growth 2024-2029 (%)
  • Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%)
• 8.4 Anti-infectives - Market size and forecast 2024-2029
  • Chart on Anti-infectives - Market size and forecast 2024-2029 ($ million)
  • Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million)
  • Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
  • Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
• 8.5 Analgesics - Market size and forecast 2024-2029
  • Chart on Analgesics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
  • Chart on Analgesics - Year-over-year growth 2024-2029 (%)
  • Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
• 8.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.7 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

9 Market Segmentation by Distribution Channel

• 9.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 9.3 Hospital pharmacies - Market size and forecast 2024-2029
  • Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
• 9.4 Retail pharmacies - Market size and forecast 2024-2029
  • Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
• 9.5 Online pharmacies - Market size and forecast 2024-2029
  • Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Type

• 10.1 Market segments
  • Chart on Type - Market share 2024-2029 (%)
  • Data Table on Type - Market share 2024-2029 (%)
• 10.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 10.3 Left ventricular assist device (LVAD) - Market size and forecast 2024-2029
  • Chart on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
  • Chart on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
  • Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
• 10.4 Heart transplantation - Market size and forecast 2024-2029
  • Chart on Heart transplantation - Market size and forecast 2024-2029 ($ million)
  • Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million)
  • Chart on Heart transplantation - Year-over-year growth 2024-2029 (%)
  • Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%)
• 10.5 Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029
  • Chart on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
  • Chart on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
  • Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
• 10.6 Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029
  • Chart on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024-2029 ($ million)
  • Chart on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
  • Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
• 10.7 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

11 Market Segmentation by Indication

• 11.1 Market segments
  • Chart on Indication - Market share 2024-2029 (%)
  • Data Table on Indication - Market share 2024-2029 (%)
• 11.2 Comparison by Indication
  • Chart on Comparison by Indication
  • Data Table on Comparison by Indication
• 11.3 Ischemic heart disease (IHD) - Market size and forecast 2024-2029
  • Chart on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
  • Chart on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
  • Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
• 11.4 Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029
  • Chart on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
  • Chart on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
  • Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
• 11.5 Valvular heart disease (VHD) - Market size and forecast 2024-2029
  • Chart on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
  • Chart on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
  • Data Table on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
• 11.6 Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029
  • Chart on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
  • Chart on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
  • Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
• 11.7 Market opportunity by Indication
  • Market opportunity by Indication ($ million)
  • Data Table on Market opportunity by Indication ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 13.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 13.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 13.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 13.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 13.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 13.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 13.9 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 13.10 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 13.11 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 13.12 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 13.13 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 13.14 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 13.15 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 13.16 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 13.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

• 14.1 Market drivers
• 14.2 Market challenges
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 14.4 Market opportunities/restraints

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 16.5 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
  • SWOT
• 16.6 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
  • SWOT
• 16.7 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
  • SWOT
• 16.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.9 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
  • SWOT
• 16.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 16.11 Intas Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd. - Overview
  • Intas Pharmaceuticals Ltd. - Product / Service
  • Intas Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 16.12 LEO Pharma AS
  • LEO Pharma AS - Overview
  • LEO Pharma AS - Product / Service
  • LEO Pharma AS - Key offerings
  • SWOT
• 16.13 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
• 16.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 16.15 Panacea Biotec Ltd.
  • Panacea Biotec Ltd. - Overview
  • Panacea Biotec Ltd. - Product / Service
  • Panacea Biotec Ltd. - Key news
  • Panacea Biotec Ltd. - Key offerings
  • SWOT
• 16.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 16.17 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 16.18 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations